mRNA-Expression of ERα, ERβ, and PR in Clonal Stem Cell Cultures Obtained from Human Endometrial Biopsies

Table 1

Clinical characteristics of patients and change of hormone receptor expression after the first cloning round.

Patient	Age (yrs)	BMI	Miscarriages	Cycle phase	Histological cycle day	Progesterone (ng/mL)	ERα FC	ERβ FC	PR FC	ERβ/ERα control	ERβ/ERα 1st cloning round
HA	25	21	0	Secretory	23	11.02	0.002	0.016	0.036	0.0151	0.1199
LK	36	19	1	Secretory	16	13.48	0.265	0.011	0.130	0.0090	0.0004
LM	36	18	0	Secretory	23	15.00	0.281	0.008	0.607	0.1490	0.0040
HM	29	25	0	Secretory	22	8.37	0.299	0.357	0.139	0.0047	0.0057
IV	24	18	1	Secretory	17	18.00	0.271	0.329	0.318	0.0082	0.0100
YA	26	24	0	Secretory	22	14.61	0.002	0.009	0.035	0.0037	0.0206
HI	38	23	3	Secretory	21	17.03	0.012	0.004	0.036	0.0124	0.0044
WS	29	34	0	Secretory	23	9.43	0.008	0.037	0.022	0.0059	0.0252
BN	35	29	3	Secretory	23	16.79	0.220	0.080	1.530	0.2645	0.0959
LF	42	25	0	Secretory	23	12.16	1.632	0.048	5.249	0.0054	0.0002
CM	32	23	1	Secretory	17	14.61	1.010	0.363	1.302	0.0005	0.0002

FC: fold change of hormone receptor expression after the first cloning round.
ER: estrogen receptor; PR: progesterone receptor.